287 related articles for article (PubMed ID: 22544367)
21. A further contribution to the delineation of the 17q21.31 microdeletion syndrome: central nervous involvement in two Italian patients.
Terrone G; D'Amico A; Imperati F; Carella M; Palumbo O; Gentile M; Canani RB; Melis D; Romano A; Parente I; Riccitelli M; Del Giudice E
Eur J Med Genet; 2012; 55(8-9):466-71. PubMed ID: 22659270
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome.
Koolen DA; Sharp AJ; Hurst JA; Firth HV; Knight SJ; Goldenberg A; Saugier-Veber P; Pfundt R; Vissers LE; Destrée A; Grisart B; Rooms L; Van der Aa N; Field M; Hackett A; Bell K; Nowaczyk MJ; Mancini GM; Poddighe PJ; Schwartz CE; Rossi E; De Gregori M; Antonacci-Fulton LL; McLellan MD; Garrett JM; Wiechert MA; Miner TL; Crosby S; Ciccone R; Willatt L; Rauch A; Zenker M; Aradhya S; Manning MA; Strom TM; Wagenstaller J; Krepischi-Santos AC; Vianna-Morgante AM; Rosenberg C; Price SM; Stewart H; Shaw-Smith C; Brunner HG; Wilkie AO; Veltman JA; Zuffardi O; Eichler EE; de Vries BB
J Med Genet; 2008 Nov; 45(11):710-20. PubMed ID: 18628315
[TBL] [Abstract][Full Text] [Related]
23. Two families with sibling recurrence of the 17q21.31 microdeletion syndrome due to low-grade mosaicism.
Koolen DA; Dupont J; de Leeuw N; Vissers LE; van den Heuvel SP; Bradbury A; Steer J; de Brouwer AP; Ten Kate LP; Nillesen WM; de Vries BB; Parker MJ
Eur J Hum Genet; 2012 Jul; 20(7):729-33. PubMed ID: 22293690
[TBL] [Abstract][Full Text] [Related]
24. Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia.
Morgan AT; Haaften LV; van Hulst K; Edley C; Mei C; Tan TY; Amor D; Fisher SE; Koolen DA
Eur J Hum Genet; 2018 Jan; 26(1):75-84. PubMed ID: 29225339
[TBL] [Abstract][Full Text] [Related]
25. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
Gropman AL; Duncan WC; Smith AC
Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
[TBL] [Abstract][Full Text] [Related]
26. [Smith-Magenis syndrome].
Livet MO; Moncla A; Delobel B; Croquette MF; Philip N; Vallée L
Arch Pediatr; 1997 Dec; 4(12):1231-7. PubMed ID: 9538429
[TBL] [Abstract][Full Text] [Related]
27. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
[TBL] [Abstract][Full Text] [Related]
28. Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome.
Koczkowska M; Wierzba J; Śmigiel R; Sąsiadek M; Cabała M; Ślężak R; Iliszko M; Kardaś I; Limon J; Lipska-Ziętkiewicz BS
J Appl Genet; 2017 Feb; 58(1):93-98. PubMed ID: 27629806
[TBL] [Abstract][Full Text] [Related]
29. Koolen-de Vries syndrome: A de novo missense KANSL1 variant.
Yimenicioglu S; Kocaaga A
Clin Neurol Neurosurg; 2022 Nov; 222():107444. PubMed ID: 36150256
[TBL] [Abstract][Full Text] [Related]
30. The neuropsychiatry and multisystem features of the Smith-Magenis syndrome: a review.
Shelley BP; Robertson MM
J Neuropsychiatry Clin Neurosci; 2005; 17(1):91-7. PubMed ID: 15746488
[TBL] [Abstract][Full Text] [Related]
31. Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome.
Khalifa M; Stein J; Grau L; Nelson V; Meck J; Aradhya S; Duby J
Am J Med Genet A; 2013 Apr; 161A(4):835-40. PubMed ID: 23494856
[TBL] [Abstract][Full Text] [Related]
32. Clinical Genetics Can Solve the Pitfalls of Genome-Wide Investigations: Lesson from Mismapping a Loss-of-Function Variant in
Bigoni S; Marangi G; Frangella S; Panfili A; Ognibene D; Squeo GM; Merla G; Zollino M
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33050294
[TBL] [Abstract][Full Text] [Related]
33. Cognitive and adaptive behavior profiles in Smith-Magenis syndrome.
Madduri N; Peters SU; Voigt RG; Llorente AM; Lupski JR; Potocki L
J Dev Behav Pediatr; 2006 Jun; 27(3):188-92. PubMed ID: 16775514
[TBL] [Abstract][Full Text] [Related]
34. A new syndrome of intellectual disability with dysmorphism due to TBL1XR1 deletion.
Pons L; Cordier MP; Labalme A; Till M; Louvrier C; Schluth-Bolard C; Lesca G; Edery P; Sanlaville D
Am J Med Genet A; 2015 Jan; 167A(1):164-8. PubMed ID: 25425123
[TBL] [Abstract][Full Text] [Related]
35. 17q21.31 microdeletion associated with infantile spasms.
Wray CD
Eur J Med Genet; 2013 Jan; 56(1):59-61. PubMed ID: 23123321
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous features in 17q21.31 deletion syndrome: a differential diagnosis for cardio-facio-cutaneous syndrome.
Wright EB; Donnai D; Johnson D; Clayton-Smith J
Clin Dysmorphol; 2011 Jan; 20(1):15-20. PubMed ID: 21084979
[TBL] [Abstract][Full Text] [Related]
37. Atypical Café-au-Lait Macules in a Patient with Koolen-de Vries Syndrome (17q21.31 Microdeletion Syndrome).
Han AM; Kusari A; Soeprono F; Eichenfield LF
Pediatr Dermatol; 2019 Jul; 36(4):e97-e98. PubMed ID: 31125459
[TBL] [Abstract][Full Text] [Related]
38. Uncommon fundus presentation of Koolen-De Vries Syndrome in a young boy.
Alomairah H; Ali A; Altemaimi R; Alabduljalil T
Ophthalmic Genet; 2024 Apr; 45(2):164-166. PubMed ID: 37528764
[TBL] [Abstract][Full Text] [Related]
39. A Chinese patient with KBG syndrome and a 9q31.2-33.1 microdeletion.
Xu M; Zhou H; Yong J; Cong P; Li C; Yu Y; Qi M
Eur J Med Genet; 2013 May; 56(5):245-50. PubMed ID: 23369839
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome.
Tan TY; Aftimos S; Worgan L; Susman R; Wilson M; Ghedia S; Kirk EP; Love D; Ronan A; Darmanian A; Slavotinek A; Hogue J; Moeschler JB; Ozmore J; Widmer R; Bruno D; Savarirayan R; Peters G
J Med Genet; 2009 Jul; 46(7):480-9. PubMed ID: 19447831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
